Activation of pulmonary C fibres by adenosine in anaesthetized rats:: role of adenosine A1 receptors

被引:72
作者
Hong, JL [1 ]
Ho, CY [1 ]
Kwong, K [1 ]
Lee, LY [1 ]
机构
[1] Univ Kentucky, Dept Physiol, Med Ctr, Lexington, KY 40536 USA
来源
JOURNAL OF PHYSIOLOGY-LONDON | 1998年 / 508卷 / 01期
关键词
D O I
10.1111/j.1469-7793.1998.109br.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1. Intravenous administration of adenosine (Ado) to patients can cause dyspnoea, chest discomfort and bronchoconstriction. To assess the role of vagal pulmonary C fibres in evoking these adverse reactions, the effect of Ado on single pulmonary C fibres was studied in anaesthetized and artificially ventilated rats. 2. Right-atrial injection of Ado (320 mu g kg(-1)) activated 68% (73/107) of pulmonary C fibres; the total number of action potentials during a period of 15 s increased from a baseline of 0.2 +/- 0.1 impulses to a peak of 16.4 +/- 2.6 impulses (P < 0.01, n = 107) after Ado. Inosine, the metabolite of Ado, did not activate any of eleven C fibres tested in six rats. Furthermore, C fibres were activated only by right-atrial and not by left-ventricular injection of the same dose of Ado. 3. Unlike the immediate and transient stimulation of C fibres by capsaicin, the C fibre stimulation by Ado had a latency of 6.5 +/- 0.3 s (range, 3-18 s) and lasted longer. 4. The stimulation of C fibres by Ado was significantly attenuated by pretreatment with aminophylline, a non-selective Ado receptor antagonist, was completely prevented by 1,3-dipropyl-8-cyclopentylxanthine, an Ado A(1) receptor antagonist, but was unaffected by 3,7-dimethy-1-propargylxanthine, an A(2) receptor antagonist. None of these Ado receptor antagonists prevented capsaicin-induced C fibre stimulation. 5. In conclusion, Ado stimulates pulmonary C fibre terminals through an activation of A(1) receptors. The stimulation of pulmonary C fibres may play an important role in Ado-induced adverse respiratory effects.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 30 条
[1]   THE CARDIAC EFFECTS OF ADENOSINE [J].
BELARDINELLI, L ;
LINDEN, J ;
BERNE, RM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1989, 32 (01) :73-97
[2]  
BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330
[3]  
BRUNS RF, 1990, ANN NY ACAD SCI, V603, P211
[4]   SAFETY PROFILE OF ADENOSINE STRESS PERFUSION IMAGING - RESULTS FROM THE ADENOSCAN-MULTICENTER-TRIAL-REGISTRY [J].
CERQUEIRA, MD ;
VERANI, MS ;
SCHWAIGER, M ;
HEO, J ;
ISKANDRIAN, AS ;
ALAZRAKI, NP ;
BEAN, LC ;
BELARDINELLI, L ;
BELL, M ;
BERMAN, DS ;
BOTVINICK, EH ;
CHEIRIF, J ;
HANSEN, CL ;
HELLER, GV ;
JOHNSTON, DL ;
LEPPO, JA ;
MADDAHI, J ;
PARKER, LS ;
MOHIUDDIN, S ;
RAICHLEN, JS ;
REIS, GJ ;
SCHELBERT, HR ;
SEALS, AA ;
STOLZENBERG, J ;
WILLIAMS, KA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (02) :384-389
[5]  
COLEMAN RA, 1994, PHARMACOL REV, V46, P305
[6]   AFFERENT VAGAL-C FIBER INNERVATION OF THE LUNGS AND AIRWAYS AND ITS FUNCTIONAL-SIGNIFICANCE [J].
COLERIDGE, JCG ;
COLERIDGE, HM .
REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY, 1984, 99 :1-110
[7]  
CRIMI N, 1992, EUR RESPIR J, V5, P560
[8]   ADENOSINE IN BRONCHOALVEOLAR LAVAGE FLUID IN ASTHMA [J].
DRIVER, AG ;
KUKOLY, CA ;
ALI, S ;
MUSTAFA, SJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (01) :91-97
[9]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
[10]   ADENOSINE ACTIVATES CARDIAC SYMPATHETIC AFFERENT-FIBERS AND POTENTIATES THE EXCITATION INDUCED BY CORONARY-OCCLUSION [J].
GNECCHIRUSCONE, T ;
MONTANO, N ;
CONTINI, M ;
GUAZZI, M ;
LOMBARDI, F ;
MALLIANI, A .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1995, 53 (2-3) :175-184